Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Batm Advanced Communications Ltd (BVC)

London
Currency in GBP
Disclaimer
18.93
-0.27(-1.41%)
Closed

BVC Price Commentary

Hey guys, interested to see what you think about BATM. Lately it has not performed well due to a number of reasons. The main one being that interest rates have increased in both recent monetary policy meetings pushing people away from equities as bonds become more attractive. Nevertheless I think this may be an attractive buying opportunity for investors for 3 main reasons:1. Strong balance sheet ($12.26 million profit after tax, up from $4.3 million the year before) 2. Diversification (BATM’s portfolio includes a mix of established and novel technologies, and targets a range of sub-segments, customer types and geographical markets)3. Return to shareholders (Reinstated dividend policy from FY 2020)Would love to hear poeple's opinions on this company and whether you guys also think that a price entry below 50 is very attractive.
https://nocamels.com/2020/05/batm-antibody-test-covid-19-israel-biomed/#utmNot true.Follow this link to discover why price is rising. They have an antibody test an antigen test and a drug tested to cure covid. Novacyt only has a Pcr antigen test. I hold both shares.
bit too late on the test kits. other companies like Biolidics Ltd and Novacyt are well ahead
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.